U.S. vaccine experts deemed thimerosal safe, removing it from most vaccines over concerns about mercury and autism links. However, anti-vaccine advocates continue to contest its safety. The CDC's ACIP has reopened the thimerosal debate, driven by new panelists with anti-vaccine beliefs, replacing established vaccine experts. This meeting raises questions about scientific governance and the implications of introducing anti-vaccine perspectives into the vaccination policy discussion, as thimerosal is present only in limited flu vaccines.
Thimerosal's removal from most U.S. vaccines over two decades ago was based on worries about mercury, despite strong evidence affirming its safety.
The new ACIP panel, now skeptical of vaccines, is set to discuss thimerosal's role again, raising concerns over the scientific integrity of the review.
Collection
[
|
...
]